The full blood count blood test for colorectal cancer detection: a systematic review, meta-analysis, and critical appraisal
Conference paper
VIRDEE P. et al, (2021)
Longitudinal progression of frailty in older population and risk of adverse events: An application of joint models
Conference paper
ELHUSSEIN L. et al, (2021)
Longitudinal progression of frailty in older population and risk of adverse events: An application of joint models
Conference paper
ELHUSSEIN L. et al, (2021)
Use of and adherence to bisphosphonates in elderly patients with complex health needs: an analysis of UK primary care records
Conference paper
ELHUSSEIN L. et al, (2021)
Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
Journal article
Robinson DE. et al, (2021), J bone miner res, 36, 820 - 832
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Journal article
Robinson DE. et al, (2021), Health technol assess, 25, 1 - 106
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
Journal article
Robinson DE. et al, (2021), Health technol assess, 25, 1 - 106
A NEW PREDICTION TOOL BASED ON ELECTRONIC MEDICAL RECORDS DATA TO ASSESS IMMINENT HIP FRACTURE RISK IN SECONDARY FRACTURE PREVENTION: A COHORT ANALYSIS INCLUDING OVER 700,000 PATIENTS FROM DENMARK, SPAIN AND THE UK
Conference paper
Pineda-Moncusi MT. et al, (2020), Osteoporosis international, 31, S52 - S52
CARDIOVASCULAR RISK FACTORS AND INCIDENCE OF CARDIOVASCULAR EVENTS IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE
Conference paper
Elhussein L. et al, (2020), Osteoporosis international, 31, S552 - S552
DEVELOPMENT AND VALIDATION OF A NEW PREDICTION TOOL TO ASSESS IMMINENT HIP FRACTURE RISK IN PATIENTS STARTING ORAL BISPHOSPHONATES: A REAL WORLD COHORT STUDY INCLUDING 373, 455 PARTICIPANTS FROM DENMARK, SPAIN AND THE UK
Conference paper
Pineda-Moncusi MT. et al, (2020), Osteoporosis international, 31, S401 - S401
The use of preventative treatments (statins, bisphosphates and anti-hypertensives) in older patients with complex health needs: An analysis of UK primary care and linked hospital data
Conference paper
He Y. et al, (2020), Pharmacoepidemiology and drug safety, 29, 297 - 297
Three strategies to measure frailty and/or complex health needs in real world data: An analysis of UK primary care and hospital linked data
Conference paper
Elhussein L. et al, (2020), Pharmacoepidemiology and drug safety, 29, 283 - 284
The Full Blood Count Blood Test for Colorectal Cancer Detection: A Systematic Review, Meta-Analysis, and Critical Appraisal.
Journal article
Virdee PS. et al, (2020), Cancers (basel), 12
Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.
Journal article
Alarkawi D. et al, (2020), J bone miner res, 35, 894 - 900
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: the Ipi-Glio trial protocol.
Journal article
Brown NF. et al, (2020), Bmc cancer, 20
Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma.
Journal article
Thomas A. et al, (2020), Eur j cancer, 124, 131 - 141
Components of the full blood count as risk factors for colorectal cancer detection: a systematic review protocol.
Journal article
Virdee PS. et al, (2019), Bmj open, 9
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
Conference paper
Woodcock VK. et al, (2019), Journal of clinical oncology, 37